Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126514201 | 12651420 | 1 | I | 20160810 | 20160815 | 20160815 | EXP | PHHY2016CN110677 | NOVARTIS | 55.00 | YR | F | Y | 58.00000 | KG | 20160815 | CN | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126514201 | 12651420 | 1 | PS | TYKERB | LAPATINIB DITOSYLATE | 1 | Oral | 5 DF, QD | 22059 | 5 | DF | TABLET | QD | ||||||
| 126514201 | 12651420 | 2 | SS | XELODA | CAPECITABINE | 1 | Oral | UNK | Y | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126514201 | 12651420 | 1 | Metastases to bone |
| 126514201 | 12651420 | 2 | Metastases to bone |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126514201 | 12651420 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126514201 | 12651420 | Diarrhoea | |
| 126514201 | 12651420 | Fatigue | |
| 126514201 | 12651420 | Haemolytic anaemia | |
| 126514201 | 12651420 | Heart rate increased | |
| 126514201 | 12651420 | Nasopharyngitis | |
| 126514201 | 12651420 | Off label use | |
| 126514201 | 12651420 | Tension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |